[1]
de Souza, M.P. et al. 2020. ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 1, 3 (Oct. 2020), 16–19. DOI:https://doi.org/10.46765/2675-374X.2020v2n1p16-19.